Browse by category

OASIS 1 trial: Oral semaglutide 50mg achieves 15.1% weight loss

Headline results from OASIS 1 - a phase 3a 68-week, efficacy and safety trial comparing once-daily oral semaglutide 50 mg for weight...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

6 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

6 days ago

Racial and ethnic groups face barriers to obtaining OMMs

6 days ago

Weekly Digest